Patent · US Active

Methods for the treatment and prevention of inflammatory diseases

US8324237B2 · kind B2 · utility

6Cited by
1References
10Claims
0Family size

Inventors

Key dates

Filing dateMay 19, 2006
Grant dateDec 4, 2012
Priority date
Expiry dateJan 24, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/685
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention includes processes mainly for the treatment of a inflammatory diseases, such as inflammatory bowel disease, arthritis, atherosclerosis, asthma, allergy, inflammatory kidney disease, circulatory shock, multiple sclerosis, chronic obstructive pulmonary disease, skin inflammation, periodontal disease, psoriasis and T cell-mediated diseases of immunity, including allergic encephalomyelitis, allergic neuritis, transplant allograft rejection, graft versus host disease, myocarditis, thyroiditis, nephritis, systemic lupus erthematosus, and insulin-dependent diabetes mellitus. The processes involve treating a patient with a pharmaceutical composition containing an active ingredient that inhibits the activity of sphingosine kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.